TNF and viral infectious disease: Collectively, these data support the neutralization of IFN-γ and TNF, or IL-1β in the post-acute stage of viral infection as viable therapeutic options to augment alveolar regeneration and dampen fibrotic sequelae observed following respiratory viral infections (Extended data Fig. 14).